Susquehanna International Group’s CorMedix CRMD Stock Holding History

Susquehanna International Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.56M	Buy	819,100 +64,600	+9%	+$478K	﹤0.01%	4048
2025 Q4	$8.77M	Sell	754,500 -51,800	-6%	-$573K	﹤0.01%	3226
2025 Q3	$9.38M	Buy	806,300 +569,700	+241%	+$6.89M	﹤0.01%	3121
2025 Q2	$2.91M	Sell	236,600 -144,400	-38%	-$1.59M	﹤0.01%	5019
2025 Q1	$2.35M	Buy	381,000 +140,500	+58%	+$1.45M	﹤0.01%	5178
2024 Q4	$1.95M	Buy	240,500 +18,600	+8%	+$186K	﹤0.01%	5371
2024 Q3	$1.79M	Sell	221,900 -25,200	-10%	-$136K	﹤0.01%	5494
2024 Q2	$1.07M	Buy	247,100 +58,600	+31%	+$298K	﹤0.01%	6411
2024 Q1	$799K	Sell	188,500 -25,200	-12%	-$87.4K	﹤0.01%	7406
2023 Q4	$804K	Sell	213,700 -19,200	-8%	-$66.1K	﹤0.01%	7526
2023 Q3	$862K	Buy	232,900 +65,600	+39%	+$261K	﹤0.01%	6963
2023 Q2	$664K	Buy	167,300 +44,500	+36%	+$220K	﹤0.01%	7645
2023 Q1	$508K	Sell	122,800 -57,700	-32%	-$236K	﹤0.01%	8527
2022 Q4	$762K	Buy	180,500 +104,200	+137%	+$369K	﹤0.01%	6785
2022 Q3	$216K	Buy	76,300 +19,300	+34%	+$80.3K	﹤0.01%	10638
2022 Q2	$229K	Sell	57,000 -14,800	-21%	-$55K	﹤0.01%	10283
2022 Q1	$393K	Buy	71,800 +21,000	+41%	+$96.2K	﹤0.01%	9583
2021 Q4	$231K	Buy	50,800 +9,300	+22%	+$46.2K	﹤0.01%	11124
2021 Q3	$193K	Sell	41,500 -48,300	-54%	-$281K	﹤0.01%	11523
2021 Q2	$616K	Sell	89,800 -63,800	-42%	-$508K	﹤0.01%	9071
2021 Q1	$1.53M	Buy	153,600 +29,100	+23%	+$306K	﹤0.01%	6591
2020 Q4	$925K	Buy	124,500 +61,500	+98%	+$418K	﹤0.01%	6896
2020 Q3	$380K	Sell	63,000 -20,200	-24%	-$101K	﹤0.01%	8238
2020 Q2	$524K	Sell	83,200 -17,800	-18%	-$82.4K	﹤0.01%	7266
2020 Q1	$363K	Buy	101,000 +50,800	+101%	+$287K	﹤0.01%	7608
2019 Q4	$365K	Sell	50,200 -16,000	-24%	-$97.8K	﹤0.01%	7609
2019 Q3	$422K	Sell	66,200 -27,400	-29%	-$230K	﹤0.01%	7652
2019 Q2	$840K	Sell	93,600 -19,300	-17%	-$151K	﹤0.01%	6085
2019 Q1	$1.07M	Buy	112,900 +105,500	+1,426%	+$951K	﹤0.01%	4909
2018 Q4	$48K	Sell	7,400 -5,380	-42%	-$36K	﹤0.01%	8497
2018 Q3	$62K	Buy	12,780 +10,480	+456%	+$25.8K	﹤0.01%	8779
2018 Q2	$3K	Buy	+2,300	New	+$2.66K	﹤0.01%	9487
2017 Q2	–	Sell	-17,900	Closed	-$146K	–	9259
2017 Q1	$146K	Buy	17,900 +13,160	+278%	+$126K	﹤0.01%	8213
2016 Q4	$36K	Sell	4,740 -9,880	-68%	-$100K	﹤0.01%	9355
2016 Q3	$184K	Sell	14,620 -2,760	-16%	-$25.8K	﹤0.01%	7639
2016 Q2	$173K	Buy	17,380 +7,460	+75%	+$114K	﹤0.01%	7721
2016 Q1	$131K	Sell	9,920 -34,640	-78%	-$336K	﹤0.01%	8297
2015 Q4	$452K	Sell	44,560 -46,740	-51%	-$538K	﹤0.01%	6952
2015 Q3	$908K	Sell	91,300 -4,480	-5%	-$69.1K	﹤0.01%	5961
2015 Q2	$1.86M	Buy	95,780 +82,020	+596%	+$2.81M	﹤0.01%	4880
2015 Q1	$677K	Buy	+13,760	New	+$326K	﹤0.01%	6554

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Susquehanna International Group's CRMD Position: Q1 2026 in Review

Susquehanna International Group reduced its CorMedix (CRMD) stake by 47% in Q1 2026, selling an estimated $1M and leaving 153,510 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #7785.

Susquehanna International Group first reported a position in CRMD in Q2 2015 and has held it in 39 quarters since. The position peaked at $5.22M in Q3 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Susquehanna International Group held 153,510 shares of CorMedix worth $1.04M as of Q1 2026.
Susquehanna International Group sold 135,374 CorMedix shares in Q1 2026, an estimated $1M.
CorMedix made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7785 holding.
Susquehanna International Group first reported a position in CorMedix in Q2 2015 and has held it in 39 quarters since.
Susquehanna International Group's CorMedix position peaked at $5.22M in Q3 2025.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.